- Home
- LITB vs CGTX Comparison
LITB vs CGTX Comparison
Compare LITB & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- CGTX
- Stock Information
- Founded
- LITB 2007
- CGTX 2007
- Country
- LITB Singapore
- CGTX United States
- Employees
- LITB N/A
- CGTX N/A
- Industry
- LITB Catalog/Specialty Distribution
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- CGTX Health Care
- Exchange
- LITB Nasdaq
- CGTX Nasdaq
- Market Cap
- LITB N/A
- CGTX 17.2M
- IPO Year
- LITB N/A
- CGTX 2021
- Fundamental
- Price
- LITB $1.00
- CGTX $0.42
- Analyst Decision
- LITB
- CGTX Strong Buy
- Analyst Count
- LITB 0
- CGTX 6
- Target Price
- LITB N/A
- CGTX $8.30
- AVG Volume (30 Days)
- LITB 21.6K
- CGTX 2.9M
- Earning Date
- LITB 03-24-2025
- CGTX 05-06-2025
- Dividend Yield
- LITB N/A
- CGTX N/A
- EPS Growth
- LITB N/A
- CGTX N/A
- EPS
- LITB N/A
- CGTX N/A
- Revenue
- LITB $333,093,000.00
- CGTX N/A
- Revenue This Year
- LITB N/A
- CGTX N/A
- Revenue Next Year
- LITB N/A
- CGTX N/A
- P/E Ratio
- LITB N/A
- CGTX N/A
- Revenue Growth
- LITB N/A
- CGTX N/A
- 52 Week Low
- LITB $0.91
- CGTX $0.34
- 52 Week High
- LITB $6.00
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- LITB 41.05
- CGTX 28.70
- Support Level
- LITB $0.92
- CGTX $0.39
- Resistance Level
- LITB $1.05
- CGTX $0.45
- Average True Range (ATR)
- LITB 0.05
- CGTX 0.05
- MACD
- LITB 0.01
- CGTX -0.00
- Stochastic Oscillator
- LITB 61.54
- CGTX 21.57
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.